Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study

Blonanserin Augmentation of Atypical Antipsychotics in Patients with Schizophrenia-Who Benefits from Blonanserin Augmentation?: An Open-Label, Prospective, Multicenter Study

Bibliographic Details
Main Authors: Woo, Young Sup, Park, Joo Eon, Kim, Do-Hoon, Sohn, Inki, Hwang, Tae-Yeon, Park, Young-Min, Jon, Duk-In, Jeong, Jong-Hyun, Bahk, Won-Myong
Format: Online
Language:English
Published: Korean Neuropsychiatric Association 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965658/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4965658/

Similar Items